-Search query
-Search result
Showing 1 - 50 of 90 items for (author: takao & m)
![](data/emdb/media/38453/emdbimg.jpg)
EMDB-38453:
Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein in complex with ACE2 (1-up state)
Method: single particle / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
![](data/emdb/media/38454/emdbimg.jpg)
EMDB-38454:
Structure of the SARS-CoV-2 EG.5.1 spike RBD in complex with ACE2
Method: single particle / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
![](data/pdb/img/8xlm.jpg)
PDB-8xlm:
Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein in complex with ACE2 (1-up state)
Method: single particle / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
![](data/pdb/img/8xln.jpg)
PDB-8xln:
Structure of the SARS-CoV-2 EG.5.1 spike RBD in complex with ACE2
Method: single particle / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
![](data/emdb/media/37648/emdbimg.jpg)
EMDB-37648:
SARS-CoV-2 EG.5.1 spike glycoprotein (1-up state)
Method: single particle / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
![](data/emdb/media/37650/emdbimg.jpg)
EMDB-37650:
SARS-CoV-2 EG.5.1 spike glycoprotein (closed-2 state)
Method: single particle / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
![](data/emdb/media/37651/emdbimg.jpg)
EMDB-37651:
SARS-CoV-2 EG.5.1 spike glycoprotein (closed-1 state)
Method: single particle / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
![](data/pdb/img/8wmd.jpg)
PDB-8wmd:
Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein (closed-2 state)
Method: single particle / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
![](data/pdb/img/8wmf.jpg)
PDB-8wmf:
Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein (closed-1 state)
Method: single particle / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
![](data/emdb/media/36905/emdbimg.jpg)
EMDB-36905:
SARS-CoV-2 BA.1 RBD with UT28-RD
Method: single particle / : Chen L, Kita S, Anraku Y, Maenaka K
![](data/emdb/media/36906/emdbimg.jpg)
EMDB-36906:
SARS-CoV-2 BA.1 spike with UT28-RD
Method: single particle / : Chen L, Kita S, Anraku Y, Maenaka K
![](data/pdb/img/8k5g.jpg)
PDB-8k5g:
Structure of the SARS-CoV-2 BA.1 RBD with UT28-RD
Method: single particle / : Chen L, Kita S, Anraku Y, Maenaka K
![](data/pdb/img/8k5h.jpg)
PDB-8k5h:
Structure of the SARS-CoV-2 BA.1 spike with UT28-RD
Method: single particle / : Chen L, Kita S, Anraku Y, Maenaka K
![](data/emdb/media/16532/emdbimg.jpg)
EMDB-16532:
Structure of Tau filaments Type I from Subacute Sclerosing Panencephalitis
Method: helical / : Qi C, Hasegawa M, Takao M, Sakai M, Akagi M, Iwasaki Y, Yoshida M, Scheres SHW, Goedert M
![](data/emdb/media/16535/emdbimg.jpg)
EMDB-16535:
Structure of Tau filaments Type II from Subacute Sclerosing Panencephalitis
Method: helical / : Qi C, Hasegawa M, Takao M, Sakai M, Akagi M, Iwasaki Y, Yoshida M, Scheres SHW, Goedert M
![](data/pdb/img/8caq.jpg)
PDB-8caq:
Structure of Tau filaments Type I from Subacute Sclerosing Panencephalitis
Method: helical / : Qi C, Hasegawa M, Takao M, Sakai M, Akagi M, Iwasaki Y, Yoshida M, Scheres SHW, Goedert M
![](data/pdb/img/8cax.jpg)
PDB-8cax:
Structure of Tau filaments Type II from Subacute Sclerosing Panencephalitis
Method: helical / : Qi C, Hasegawa M, Takao M, Sakai M, Akagi M, Iwasaki Y, Yoshida M, Scheres SHW, Goedert M
![](data/emdb/media/34741/emdbimg.jpg)
EMDB-34741:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/emdb/media/34742/emdbimg.jpg)
EMDB-34742:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11 focused on RBD and NIV-11 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/pdb/img/8hgl.jpg)
PDB-8hgl:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/pdb/img/8hgm.jpg)
PDB-8hgm:
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/emdb/media/33820/emdbimg.jpg)
EMDB-33820:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 focused on RBD and NIV-8 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/emdb/media/33821/emdbimg.jpg)
EMDB-33821:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/emdb/media/33822/emdbimg.jpg)
EMDB-33822:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/emdb/media/33823/emdbimg.jpg)
EMDB-33823:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 focused on RBD and NIV-10 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/emdb/media/33824/emdbimg.jpg)
EMDB-33824:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/emdb/media/33825/emdbimg.jpg)
EMDB-33825:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/emdb/media/33826/emdbimg.jpg)
EMDB-33826:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 3)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/emdb/media/33827/emdbimg.jpg)
EMDB-33827:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 focused on RBD and NIV-13 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/emdb/media/33828/emdbimg.jpg)
EMDB-33828:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/emdb/media/33829/emdbimg.jpg)
EMDB-33829:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/emdb/media/33830/emdbimg.jpg)
EMDB-33830:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 3)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/pdb/img/7yh6.jpg)
PDB-7yh6:
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-8
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/pdb/img/7yh7.jpg)
PDB-7yh7:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
![](data/emdb/media/35622/emdbimg.jpg)
EMDB-35622:
SARS-CoV-2 XBB.1 spike glycoprotein (closed-1 state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
![](data/emdb/media/35623/emdbimg.jpg)
EMDB-35623:
SARS-CoV-2 XBB.1 spike glycoprotein (closed-2 state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
![](data/emdb/media/35624/emdbimg.jpg)
EMDB-35624:
SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (1-up state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
![](data/emdb/media/35625/emdbimg.jpg)
EMDB-35625:
SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (2-up state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
![](data/emdb/media/35626/emdbimg.jpg)
EMDB-35626:
SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 focused on RBD-ACE2 interface
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
![](data/pdb/img/8ios.jpg)
PDB-8ios:
Structure of the SARS-CoV-2 XBB.1 spike glycoprotein (closed-1 state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
![](data/pdb/img/8iot.jpg)
PDB-8iot:
Structure of the SARS-CoV-2 XBB.1 spike glycoprotein (closed-2 state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
![](data/pdb/img/8iou.jpg)
PDB-8iou:
Structure of SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (1-up state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
![](data/pdb/img/8iov.jpg)
PDB-8iov:
Structure of SARS-CoV-2 XBB.1 spike RBD in complex with ACE2
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
![](data/emdb/media/16603/emdbimg.jpg)
EMDB-16603:
Type2 alpha-synuclein filament assembled in vitro by wild-type and mutant (7 residues insertion) protein
Method: helical / : Yang Y, Garringer JH, Shi Y, Lovestam S, Sew PC, Zhang XJ, Kotecha A, Bacioglu M, Koto A, Takao M, Spillantini GM, Ghetti B, Vidal R, Murzin GA, Scheres HWS, Goedert M
![](data/emdb/media/16604/emdbimg.jpg)
EMDB-16604:
Alpha-synuclein filament assembled in vitro with mutant (7 residues insertion) protein
Method: helical / : Yang Y, Garringer JH, Shi Y, Lovestam S, Sew PC, Zhang XJ, Kotecha A, Bacioglu M, Koto A, Takao M, Spillantini GM, Ghetti B, Vidal R, Murzin GA, Scheres HWS, Goedert M
![](data/emdb/media/16608/emdbimg.jpg)
EMDB-16608:
WT alpha-synuclein filament assembled in vitro
Method: helical / : Yang Y, Garringer JH, Shi Y, Lovestam S, Sew PC, Zhang XJ, Kotecha A, Bacioglu M, Koto A, Takao M, Spillantini GM, Ghetti B, Vidal R, Murzin GA, Scheres HWS, Goedert M
![](data/pdb/img/8ceb.jpg)
PDB-8ceb:
Type2 alpha-synuclein filament assembled in vitro by wild-type and mutant (7 residues insertion) protein
Method: helical / : Yang Y, Garringer JH, Shi Y, Lovestam S, Sew PC, Zhang XJ, Kotecha A, Bacioglu M, Koto A, Takao M, Spillantini GM, Ghetti B, Vidal R, Murzin GA, Scheres HWS, Goedert M
![](data/emdb/media/16600/emdbimg.jpg)
EMDB-16600:
Type1 alpha-synuclein filament assembled in vitro by wild-type and mutant (7 residues insertion) protein
Method: helical / : Yang Y, Garringer JH, Shi Y, Lovestam S, Sew PC, Zhang XJ, Kotecha A, Bacioglu M, Koto A, Takao M, Spillantini GM, Ghetti B, Vidal R, Murzin GA, Scheres HWS, Goedert M
![](data/pdb/img/8ce7.jpg)
PDB-8ce7:
Type1 alpha-synuclein filament assembled in vitro by wild-type and mutant (7 residues insertion) protein
Method: helical / : Yang Y, Garringer JH, Shi Y, Lovestam S, Peak-Chew SY, Zhang XJ, Kotecha A, Bacioglu M, Koto A, Takao M, Spillantini GM, Ghetti B, Vidal R, Murzin GA, Scheres HWS, Goedert M
![](data/emdb/media/16188/emdbimg.jpg)
EMDB-16188:
Cryo-EM structure of alpha-synuclein singlet filament from Juvenile-onset synucleinopathy
Method: helical / : Yang Y, Garringer JH, Shi Y, Zhang XJ, Kotecha A, Bacioglu M, Koto A, Takao M, Spillantini GM, Ghetti B, Vidal R, Murzin GA, Scheres HWS, Goedert M, Hasegawa M, Lashley T
Pages: